1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. FULCRUM THERAPEUTICS INC

Fulcrum Therapeutics Inc XNAS: FULC

Fulcrum Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Momentum Trap
about

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule ...

Read More

6.92 -0.11 (-1.56%)

31.69% Fall from 52W High

2,472 XNAS Volume

XNAS 05 Jun, 2025 9:36 AM (EDT)

Watchlist

Portfolio

Share
Board Meeting
The next board meeting for Fulcrum Therapeutics Inc is on 11 Jun 2025 for the purpose of 46th Annual Goldman Sachs Global Healthcare Conference See details
Durability score
Low Financial Strength
27.8 / 100
Valuation Score
Expensive Valuation
18.3 / 100
Momentum Score
Technically Moderately Bullish
66.3 / 100
Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM
Analyst Price Target
8
1Yr Price target upside is 9%
7 analysts

20

S

6

W

1

O

2

T

SWOT Analysis

Fulcrum Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..

Fulcrum Therapeutics Inc FAQ

How is Fulcrum Therapeutics Inc today?
Fulcrum Therapeutics Inc today is trading in the red, and is down by -1.56% at 6.92.
Fulcrum Therapeutics Inc is currently trading down -1.56% on an intraday basis. In the past week the stock rose 0.29%. stock has been up 111.62% in the past quarter and fell -14.99% in the past year. You can view this in the overview section.